EP3149031
T-FRUMUVIÐTAKAR SEM BEINAST GEGN VÖRTUVEIRU 16 E7 Í MÖNNUM
:
EP einkaleyfi í gildi á Íslandi:
29.5.2015:
18.12.2019:
15729004.0
:
11.3.2020:
15.4.2020
:
28.5.2035:
28.5.2026:
31.5.2026
:
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
29.5.2015
18.12.2019
11.3.2020
15.4.2020
28.5.2026
:
The United States of America, as represented by The Secretary, Department of Health and Human Services:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
:
HINRICHS, Christian S.:
Bethesda, Maryland 20817, US
:
ROSENBERG, Steven A.:
Potomac, Maryland 20854, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201462004335 P:
29.5.2014:
US
:
US2015033129:
29.5.2015
:
C07K 14/725, A61K 38/17
: 6
: 30.4.2020
: 28.5.2021
: Sigurjónsson & Thor ehf.
: 7
: 8.4.2021
: 28.5.2022
: Árnason Faktor ehf.
: 8
: 3.5.2022
: 28.5.2023
: Patice ehf.
: 9
: 23.5.2023
: 28.5.2024
: Árnason Faktor ehf.
: 10
: 7.5.2024
: 28.5.2025
: Árnason Faktor ehf.
: 11
: 16.5.2025
: 28.5.2026
: Árnason Faktor ehf.